Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
16.20
+0.03 (0.19%)
At close: Nov 7, 2025, 4:00 PM EST
15.53
-0.67 (-4.15%)
After-hours: Nov 7, 2025, 5:10 PM EST
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $493.55 million as of November 7, 2025. Its market cap has decreased by -77.32% in one year.
Market Cap
493.55M
Enterprise Value
-182.49M
1-Year Change
-77.32%
Ranking
Category
Stock Price
$16.20
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $493.55M, an increase of 28.09%. That is a compound annual growth rate of 4.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 493.55M | -23.03% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
| Apr 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 828.96B |
| Johnson & Johnson | 448.13B |
| AbbVie | 383.12B |
| UnitedHealth Group | 296.88B |
| AstraZeneca | 251.76B |
| Novartis AG | 240.29B |
| Abbott Laboratories | 216.56B |
| Thermo Fisher Scientific | 213.27B |